Last €100.31 EUR
Change Today +0.56 / 0.56%
Volume 1.3M
BAYN On Other Exchanges
Symbol
Exchange
OTC US
OTC US
BrsaItaliana
Mexico
Continuous
As of 12:45 PM 07/23/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Marijn E. Dekkers Ph.D.

Chairman of Management Board and Chief Executive Officer, Bayer AG
AgeTotal Calculated CompensationThis person is connected to 19 board members in 2 different organizations across 12 different industries.

See Board Relationships
57€5,509,000
As of Fiscal Year 2013

Background*

Dr. Marijn E. Dekkers, Ph.D., has been Chairman of the Management Board and Chief Executive Officer of Bayer AG since October 1, 2010. Dr. Dekkers served as a Member of Management Board at Bayer Pharma AG (formerly, Bayer Schering Pharma AG) since January 1, 2010. Dr. Dekkers served as the Chief Executive Officer of Bayer HealthCare AG since October 1, 2010. He also served as an Interim Head of Bayer HealthCare subgroup from May 1 to August 14, 2010. In 1988, he returned ...

Read Full Background

Corporate Headquarters*

Kaiser-Wilhelm-Allee 1
Leverkusen, North Rhine-Westphalia 51368

Germany

Phone: 49 214 301
Fax: --

Board Members Memberships*

2000-2009
Former Chief Executive Officer, President, Director and Member of Strategy Review Committee
2000-N/A
Former Director
2007-N/A
Director and Member of Compensation & Management Development Committee
2007-2009
Former Director and Member of Compensation & Management Development Committee
2012-Present
Independent Director and Member of Management Development & Compensation Committee

Education*

Bachelor's Degree
Radboud University Nijmegen
Doctorate 1985
Technische Universiteit Eindhoven
Master's Degree
Technische Universiteit Eindhoven

Other Affiliations*

Annual Compensation*

Salary€1,347,000
Bonus€1,532,000
Total Annual Compensation€2,879,000

Stock Options*

Restricted Stock Awards€1,914,000
All Other Compensation€716,000

Total Compensation*

Total Annual Cash Compensation€3,595,000
Total Short Term Compensation€2,879,000
Other Long Term Compensation€2,630,000
Total Calculated Compensation€5,509,000
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BAYN:GR €100.31 EUR +0.56

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Paulus Gerardus Josephus Maria Polman Chief Executive Officer and Director
Unilever plc
€3.1M
Andrew Philip Witty Chief Executive Officer, Executive Director, Member of Corporate Administration & Transactions Committee and Member of Finance Committee
GlaxoSmithKline plc
2.9M GBP
Kenneth C. Frazier Chairman and Chief Executive Officer
Merck & Co. Inc.
$1.5M
Christopher A. Viehbacher Chief Executive Officer, Director and Member of Strategy Committee
Sanofi
€3.0M
Pierre-André de Chalendar Chairman, Chief Executive Officer and Member of Strategy & Corporate Social Responsibility Committee
Compagnie de Saint-Gobain
€2.0M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BAYER AG-REG, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.